Nasir Noormohamed

Nasir Noormohamed has extensive experience in leadership and advisory roles within the healthcare and financial sectors. Currently serving as an Advisor on the Board of Drug Intelligence since June 1992, Nasir Noormohamed has played a pivotal role in the company's growth, recently congratulating Tazmin Merali for stepping into the CEO position. As the Board Chair for In-Common Laboratories since June 2021, Nasir Noormohamed oversees the organization, which focuses on delivering cost-effective testing and logistical services. Previously, Nasir Noormohamed held management positions at Barclays Bank of Canada, specializing in internal financial analysis. Educational achievements include a Master of Health Science in Health Administration from the University of Toronto, a Bachelor of Arts in Economics and Financial Studies from Western University, and an Executive Program from Harvard Business School.